Doubts were growing on Thursday over whether ambitious plans by European governments to use contact-tracing apps to fight the spread of the coronavirus will be able to be implemented with any real effectiveness soon.
In contrast, there appeared to be some movement forward in the sprint to find a vaccine against COVID-19, bolstered by a USD 1 billion investment from the U.S. vaccine agency.
British Prime Minister Boris Johnson pledged Wednesday to have a test, track and trace program for COVID-19 in place by June 1 as part of a strategy to persuade the country that it's safe to move on to the next stage of easing the lockdown and restarting the economy.
But the government also appeared to backtrack on an earlier pledge to make a smart phone app a pillar of that program.
Security minister James Brokenshire told the BBC on Thursday that he remains confident that the tracing system will be in place by June 1, but acknowledged that an app intended to help track the virus was not ready. He suggested technical issues were the reason for its failure to be introduced as planned by mid-May.
Experts say that being able to quickly identify people exposed to the virus can help stop the spread of the contagious respiratory illness, but efforts to put apps in place have come up across technical problems and fears of privacy intrusions.
The French government has also been forced to delay deployment of its planned contact-tracing app.
Initially expected last week as the country started lifting confinement measures, it won't be ready before next month due to technical issues and concerns over privacy.
Italian Premier Giuseppe Conte said Thursday that the country's contact-tracing app would begin tests in the coming days.
But he made no mention of whether Italy had hired teams of contact-tracers to actually conduct interviews and get in touch with people who had been in contact with COVID-19 patients, as other European countries have done.
Spain's Economy Minister, Nadia Calvio, said Wednesday in parliament that Spain is making preparations to test a European Bluetooth-based app at the end of June in the Canary Islands.
But the adoption of the app has taken a back seat to the hiring of old-school human tracers in Spain. The government has said that the technology will be adopted only if it adds value to the tracing efforts that are being deployed by the country's 17 regional administrations.
Meanwhile, drug maker AstraZeneca said Thursday it has secured the first agreements for 400 million doses of a COVID-19 vaccine that is now being tested at the University of Oxford, one of the most advanced projects in the search for a vaccine.
The Anglo-Swedish company reported it had received more than USD 1 billion from the U.S. Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine, starting this fall.
AstraZeneca CEO Pascal Soriot said the company will do everything in our power to make this vaccine quickly and widely available.''
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
